Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
暂无分享，去创建一个
J. Gisbert | P. Higgins | A. Hart | I. Dotan | P. Lakatos | J. Terdiman | M. Abreu | M. Chaparro | E. Israeli | A. Swaminath | K. Katsanos | S. Ben-Horin | C. Steenholdt | J. Brynskov | P. Ellul | L. Katz | B. Lashner | T. Nathan | G. Mantzaris | A. Atreja | E. Tsianos | Y. Ron | J. C. van der Woude | Laura H. Yun | Beth Manoogian | Kirk K. Lin | Somal Shah | Mads Naundrup Svendsen